Royal Bank of Canada’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Buy
26,269
+15,190
+137% +$825K ﹤0.01% 3249
2026
Q1
$428K Sell
11,079
-4,988
-31% -$207K ﹤0.01% 4262
2025
Q4
$746K Sell
16,067
-514
-3% -$24.8K ﹤0.01% 3867
2025
Q3
$814K Buy
16,581
+11,396
+220% +$596K ﹤0.01% 4133
2025
Q2
$268K Buy
+5,185
New +$210K ﹤0.01% 4941

Other funds holding HNGE

Royal Bank of Canada's HNGE Position: Q2 2026 in Review

Royal Bank of Canada increased its Hinge Health (HNGE) stake by 137% in Q2 2026, buying an estimated $825K and bringing the position to 26,269 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3249.

Royal Bank of Canada first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Royal Bank of Canada held 26,269 shares of Hinge Health worth $2.18M as of Q2 2026.
  • Royal Bank of Canada bought 15,190 Hinge Health shares in Q2 2026, an estimated $825K.
  • Hinge Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #3249 holding.
  • Royal Bank of Canada first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.